home
PAH
preclinical development
current page
contact

Board of Directors

Anatoly Langer, MD, MSc, FRCPC, FACC

Michael Moniz

Beth Rhodes, MSc (Chairperson of the Board)

Kim Connelly, FRACP, PhD, MBBS

Howard Leong-Poi, MD, FRCPC, FACC, FASE.

Advisor

Duncan Stewart, MD

Management

Eric DesRosiers, Ph.D., M.B.A. - President

Vatche Tchakmakian, CPA - Vice-President Finance

Michael Callahan, MD, DTM&H (UK), MSPH - Chief Medical Officer

John Hess, J.D. - Secretary

David Courtman, Ph.D. - Chief Scientific Officer

Shirley H.J. Mei, M.Sc., Ph.D. - Chief Operating Officer

Josée Champagne, Associate Director Clinical Development

Jackie Whyte, M.Sc., CCRP, - Clinical Trial Manager